Atlas Trials

Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker

Clinical trial NCT00823849 · COMPLETED

Trial details

NCT number
NCT00823849
Sponsor
Otsuka Beijing Research Institute
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 Diabetes MellitusArteriosclerosis Obliterans
Start date
2008-10-01
Primary completion
2009-08-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.